CN109563049B - 作为eaat3抑制剂的咪唑化合物 - Google Patents
作为eaat3抑制剂的咪唑化合物 Download PDFInfo
- Publication number
- CN109563049B CN109563049B CN201780045776.7A CN201780045776A CN109563049B CN 109563049 B CN109563049 B CN 109563049B CN 201780045776 A CN201780045776 A CN 201780045776A CN 109563049 B CN109563049 B CN 109563049B
- Authority
- CN
- China
- Prior art keywords
- tert
- butyl
- benzamide
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16193871 | 2016-10-14 | ||
| EP16193871.7 | 2016-10-14 | ||
| PCT/EP2017/075875 WO2018069362A1 (en) | 2016-10-14 | 2017-10-11 | Imidazole compounds as eaat3 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109563049A CN109563049A (zh) | 2019-04-02 |
| CN109563049B true CN109563049B (zh) | 2022-11-29 |
Family
ID=57136749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780045776.7A Expired - Fee Related CN109563049B (zh) | 2016-10-14 | 2017-10-11 | 作为eaat3抑制剂的咪唑化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10556870B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3526201B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7068277B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109563049B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018069362A1 (cg-RX-API-DMAC7.html) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882926A (en) * | 1993-10-20 | 1999-03-16 | Oregon Health Sciences University | Excitatory amino acid transporter gene and uses |
| WO2009077365A1 (en) * | 2007-12-17 | 2009-06-25 | F. Hoffmann-La Roche Ag | Novel imidazole-substituted arylamides |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006151954A (ja) | 2004-10-27 | 2006-06-15 | Taisho Pharmaceut Co Ltd | アスパラギン酸誘導体 |
| US7939556B2 (en) | 2005-10-14 | 2011-05-10 | Neurosearch A/S | Imidazole derivatives and their use for modulating the GABAA receptor complex |
| ES2596706T3 (es) | 2006-06-29 | 2017-01-11 | F. Hoffmann-La Roche Ag | Arilamidas con sustitución de tetrazol |
| KR101186704B1 (ko) | 2007-10-04 | 2012-09-27 | 에프. 호프만-라 로슈 아게 | 테트라졸-치환된 아릴 아마이드 유도체 및 이의 용도 |
| WO2009058298A1 (en) * | 2007-10-31 | 2009-05-07 | Merck & Co., Inc. | P2x3, receptor antagonists for treatment of pain |
| KR101405746B1 (ko) | 2007-12-17 | 2014-06-10 | 에프. 호프만-라 로슈 아게 | 트리아졸 치환된 아릴아미드 유도체 및 p2x3 및/또는 p2x2/3 퓨린성 수용체 길항제로서의 용도 |
| DK2234976T3 (da) | 2007-12-17 | 2013-06-24 | Hoffmann La Roche | Nye pyrazol-substituerede arylamider |
| TW201006801A (en) | 2008-07-18 | 2010-02-16 | Lilly Co Eli | Imidazole carboxamides |
| US20110237578A1 (en) | 2008-09-18 | 2011-09-29 | Zhi-Liang Wei | Amide compounds, compositions and uses thereof |
| CA2741666C (en) | 2008-10-31 | 2017-04-11 | Merck Sharp & Dohme Corp. | P2x3, receptor antagonists for treatment of pain |
| EP3542813A1 (en) * | 2013-05-31 | 2019-09-25 | The A2 Milk Company Limited | Beta-casein a2 and prevention of inflammation of the bowel |
| CN105555766A (zh) * | 2013-07-18 | 2016-05-04 | 诺华股份有限公司 | 作为补体因子d抑制剂的氨基甲基-联芳基衍生物及其应用 |
| US10577332B2 (en) | 2015-04-23 | 2020-03-03 | Hoffmann-La Roche Inc. | Tetrazole derivatives |
| CN107531642B (zh) | 2015-06-04 | 2021-06-22 | 豪夫迈·罗氏有限公司 | 咪唑衍生物 |
| JP6846363B2 (ja) | 2015-07-14 | 2021-03-24 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 2−フェニル−6−イミダゾリル−ピリジン−4−カルボキサミド誘導体及びそのeaat3阻害剤としての使用 |
| WO2017025523A1 (en) | 2015-08-12 | 2017-02-16 | F. Hoffmann-La Roche Ag | Pyridine and pyrimidine derivatives |
| WO2017060202A1 (en) | 2015-10-06 | 2017-04-13 | F. Hoffmann-La Roche Ag | Triazole derivatives |
| ITUB20154829A1 (it) | 2015-10-27 | 2017-04-27 | Giuseppe Galtieri | Dispositivo ad impulsi dinamici da traffico veicolare e relativo kit. |
| EP3411365B1 (en) | 2016-02-02 | 2019-11-20 | H. Hoffnabb-La Roche Ag | Pyrazol-pyridine derivatives as eaat3 inhibitors |
| CN109071451B (zh) | 2016-05-27 | 2022-07-15 | 豪夫迈·罗氏有限公司 | 作为eaat3抑制剂的吡唑化合物 |
-
2017
- 2017-10-11 WO PCT/EP2017/075875 patent/WO2018069362A1/en not_active Ceased
- 2017-10-11 EP EP17780444.0A patent/EP3526201B1/en active Active
- 2017-10-11 JP JP2019514255A patent/JP7068277B2/ja not_active Expired - Fee Related
- 2017-10-11 CN CN201780045776.7A patent/CN109563049B/zh not_active Expired - Fee Related
-
2019
- 2019-04-12 US US16/382,540 patent/US10556870B2/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882926A (en) * | 1993-10-20 | 1999-03-16 | Oregon Health Sciences University | Excitatory amino acid transporter gene and uses |
| WO2009077365A1 (en) * | 2007-12-17 | 2009-06-25 | F. Hoffmann-La Roche Ag | Novel imidazole-substituted arylamides |
Non-Patent Citations (2)
| Title |
|---|
| Synthesis and preliminary pharmacological evaluation of novel derivatives of L-b-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3;Terri L. Mavencamp,等;《Bioorganic & Medicinal Chemistry》;20080808;7740-7748 * |
| The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes;Richard J. Bridges,等;《Pharmacology & Therapeutics》;20050901;第107卷(第3期);271-285 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019532050A (ja) | 2019-11-07 |
| US10556870B2 (en) | 2020-02-11 |
| EP3526201A1 (en) | 2019-08-21 |
| WO2018069362A1 (en) | 2018-04-19 |
| CN109563049A (zh) | 2019-04-02 |
| EP3526201B1 (en) | 2020-11-18 |
| JP7068277B2 (ja) | 2022-05-16 |
| US20190233379A1 (en) | 2019-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110267945A (zh) | 氰基取代的吲哚化合物及其作为lsd1抑制剂的用途 | |
| CN107207449B (zh) | 用于治疗精神障碍的四唑衍生物 | |
| CN107922391B (zh) | 吡啶和嘧啶衍生物 | |
| CN107531642A (zh) | 咪唑衍生物 | |
| CN107922381B (zh) | 吡啶或嘧啶衍生物 | |
| TW200416030A (en) | Therapeutic proline derivatives | |
| CN108137566B (zh) | 三唑衍生物 | |
| EP3411365B1 (en) | Pyrazol-pyridine derivatives as eaat3 inhibitors | |
| CN109071451B (zh) | 作为eaat3抑制剂的吡唑化合物 | |
| US10556870B2 (en) | Imidazole compounds as EAAT3 inhibitors | |
| HK40004826B (en) | Imidazole compounds as eaat3 inhibitors | |
| HK40004826A (en) | Imidazole compounds as eaat3 inhibitors | |
| HK1262810A1 (en) | Pyrazol compounds as eaat3 inhibitors | |
| HK1262810B (en) | Pyrazol compounds as eaat3 inhibitors | |
| HK1254202B (en) | Triazole derivatives | |
| HK1245269B (en) | Imidazole derivatives | |
| HK1247192B (en) | Pyridine or pyrimidine derivatives | |
| HK1251226B (en) | Pyridine and pyrimidine derivatives | |
| HK1241878B (en) | Tetrazole derivatives for use in the treatment of psychiatric disorders | |
| HK1252767B (en) | Pyrazol-pyridine derivatives as eaat3 inhibitors | |
| HK1250028B (en) | 2-phenyl-6-imidazolyl-pyridine-4-carboxamide derivatives and their use as eaat3 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40004826 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20221129 |